Welcome to the
Symposia and Workshops
of the Falk Foundation

Scientific dialogue

The Falk Foundation has been organizing internationally recognized scientific symposia and workshops in the fields of gastroenterology and hepatology since 1967. So far, the foundation has arranged over 270 events, which have drawn in some 130,000 participants from over 110 countries.
Falk Foundation’s events provide scientific and medical information of an outstanding quality, and attract some of the most renowned speakers in the field.

Inflammatory bowel diseases The challenging road to personalized medicine

Symposium 214, Oxford (Great Britain), March 2019

Oxford. The call for personalized medicine, currently heard louder and louder in almost all medical specialties, does not stop at inflammatory bowel diseases. Gastroenterologists hope that this will deliver highly effective and at the same time well-tolerated treatments for each patient. The road to this goal is challenging because it requires intensive basic research in the fields of pathophysiology, genetics and immunology.
more...

Future prospects for inflammatory bowel disease
Predictive medicine: Using biomarkers to predict the success of therapy

Symposium 213, Milan (Italy), October 2018

Milan. Over the past few years, the therapeutic possibilities for inflammatory bowel diseases (IBD) have expanded considerably. This trend looks set to continue in the future. For this reason, the question of when which patient should receive which therapy is becoming even more significant.
More...

Bile acid research: Basis for new therapeutic concepts
UDCA and norUDCA: two bile acids with a future, not just in hepatology

Symposium 211, Dublin (Ireland), July 2018

Dublin. The interest was enormous: The XXV Bile Acid Meeting of the Falk Foundation e.V. in Dublin was attended by 520 scientists from about 40 countries – more than ever before. This underlines the increasing importance of bile acid research, not only for basic researchers, but also for clinical research.
More...

Inflammatory bowel diseases
A change in perspective is pending with regard to diagnostics and therapy

Symposium 210, Lisbon (Portugal), April 2018

Lisbon. “Big data” is also currently making its arrival with regard to inflammatory bowel diseases (IBD). For instance, there is an outright flood of data regarding factors which determine pathophysiology – from genome via the exposome and immunome to microbiome. 
More...

Liver-Bowel-Microbiome Interactions
On the road to personalized nutritional therapy
Workshop, Hamburg (Germany), January 2018
More...